155 related articles for article (PubMed ID: 38207154)
21.
Panarese A; Galatola G; Armentano R; Pimentel-Nunes P; Ierardi E; Caruso ML; Pesce F; Lenti MV; Palmitessa V; Coletta S; Shahini E
World J Gastroenterol; 2020 Jul; 26(26):3834-3850. PubMed ID: 32774061
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors.
Yun CY; Kim N; Lee J; Lee JY; Hwang YJ; Lee HS; Yoon H; Shin CM; Park YS; Kim JW; Lee DH
Helicobacter; 2018 Dec; 23(6):e12542. PubMed ID: 30303591
[TBL] [Abstract][Full Text] [Related]
23. Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging.
Rugge M; Sugano K; Scarpignato C; Sacchi D; Oblitas WJ; Naccarato AG
Helicobacter; 2019 Apr; 24(2):e12571. PubMed ID: 30773732
[TBL] [Abstract][Full Text] [Related]
24. Effect of biopsy site on detection of gastric cancer high-risk groups by OLGA and OLGIM stages.
Kim YI; Kook MC; Cho SJ; Lee JY; Kim CG; Joo J; Choi IJ
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28940945
[TBL] [Abstract][Full Text] [Related]
25. First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile.
Marcos-Pinto R; Dinis-Ribeiro M; Carneiro F; Wen X; Lopes C; Figueiredo C; Machado JC; Ferreira RM; Reis CA; Canedo P; Durães C; Ferreira J; Pedroto I; Areias J
Virchows Arch; 2013 Sep; 463(3):391-9. PubMed ID: 23887584
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for gastric cancer in patients with Lynch syndrome.
Ortigão R; Brito M; Pinto C; Sá I; Libânio D; Dinis-Ribeiro M; Brandão C
Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):912-918. PubMed ID: 35830349
[TBL] [Abstract][Full Text] [Related]
27. ROLE OF INCISURA ANGULARIS BIOPSY IN GASTRITIS STAGING AND RISK ASSESSMENT OF GASTRIC CÂNCER.
Ferrari F; Ogata DC; Mello CAL
Arq Gastroenterol; 2023; 60(4):478-489. PubMed ID: 38018553
[TBL] [Abstract][Full Text] [Related]
28. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems.
Cho SJ; Choi IJ; Kook MC; Nam BH; Kim CG; Lee JY; Ryu KW; Kim YW
Aliment Pharmacol Ther; 2013 Nov; 38(10):1292-302. PubMed ID: 24134499
[TBL] [Abstract][Full Text] [Related]
29. [Staging gastritis with the OLGA system: prevalence of advanced stages of gastric atrophy in Mexican patients].
Ramírez-Mendoza P; Ruiz-Castillo SA; Maroun-Marun C; Trujillo-Benavides O; Baltazar-Montúfar P; Méndez del Monte R; Angeles-Garay U
Rev Gastroenterol Mex; 2011; 76(4):302-8. PubMed ID: 22188954
[TBL] [Abstract][Full Text] [Related]
30. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis.
Yue H; Shan L; Bin L
Gastric Cancer; 2018 Jul; 21(4):579-587. PubMed ID: 29460004
[TBL] [Abstract][Full Text] [Related]
31. Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori -associated gastric diseases.
Guo DL; Dong M; Wang L; Sun LP; Yuan Y
World J Gastroenterol; 2002 Dec; 8(6):1009-13. PubMed ID: 12439915
[TBL] [Abstract][Full Text] [Related]
32. Relation of cyclooxygenase-2 expression with premalignant gastric lesions.
Ogutmen Koc D; Kimiloglu E
Acta Gastroenterol Belg; 2020; 83(2):249-254. PubMed ID: 32603043
[TBL] [Abstract][Full Text] [Related]
33. Kyoto classification risk scoring system and endoscopic grading of gastric intestinal metaplasia for gastric cancer: Multicenter observation study in Japan.
Kawamura M; Uedo N; Koike T; Kanesaka T; Hatta W; Ogata Y; Oikawa T; Iwai W; Yokosawa S; Honda J; Asonuma S; Okata H; Ohyauchi M; Ito H; Abe Y; Ara N; Kayaba S; Shinkai H; Shimokawa T
Dig Endosc; 2022 Mar; 34(3):508-516. PubMed ID: 34415621
[TBL] [Abstract][Full Text] [Related]
34. Microbiota according to gastric topography in patients with low or high risk of gastric cancer in Nariño, Colombia.
Caguazango JC; Pazos ÁJ
Biomedica; 2019 Aug; 39(Supl. 2):157-171. PubMed ID: 31529842
[TBL] [Abstract][Full Text] [Related]
35. Chronic atrophic antral gastritis and risk of metaplasia and dysplasia in an area with low prevalence of Helicobacter pylori.
Yeh LY; Raj M; Hassan S; Aziz SA; Othman NH; Mutum SS; Naik VR
Indian J Gastroenterol; 2009; 28(2):49-52. PubMed ID: 19696988
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune gastritis: long-term natural history in naïve
Rugge M; Bricca L; Guzzinati S; Sacchi D; Pizzi M; Savarino E; Farinati F; Zorzi M; Fassan M; Dei Tos AP; Malfertheiner P; Genta RM; Graham DY
Gut; 2023 Jan; 72(1):30-38. PubMed ID: 35772926
[TBL] [Abstract][Full Text] [Related]
37. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia.
Isajevs S; Savcenko S; Liepniece-Karele I; Piazuelo MB; Kikuste I; Tolmanis I; Vanags A; Gulbe I; Mezmale L; Samentaev D; Tazedinov A; Samsutdinov R; Belihina T; Igissinov N; Leja M
Virchows Arch; 2021 Oct; 479(4):679-686. PubMed ID: 33990867
[TBL] [Abstract][Full Text] [Related]
38. Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia.
Quach DT; Le HM; Hiyama T; Nguyen OT; Nguyen TS; Uemura N
Helicobacter; 2013 Apr; 18(2):151-7. PubMed ID: 23167960
[TBL] [Abstract][Full Text] [Related]
39. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
Rugge M; Meggio A; Pravadelli C; Barbareschi M; Fassan M; Gentilini M; Zorzi M; Pretis G; Graham DY; Genta RM
Gut; 2019 Jan; 68(1):11-17. PubMed ID: 29306868
[TBL] [Abstract][Full Text] [Related]
40. OLGA staging for gastritis: a tutorial.
Rugge M; Correa P; Di Mario F; El-Omar E; Fiocca R; Geboes K; Genta RM; Graham DY; Hattori T; Malfertheiner P; Nakajima S; Sipponen P; Sung J; Weinstein W; Vieth M
Dig Liver Dis; 2008 Aug; 40(8):650-8. PubMed ID: 18424244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
